RaySearch Laboratories AB (CHIX:RAYBS) Other Financing: kr-0 Mil (TTM As of Mar. 2026)


CHIX:RAYBS RaySearch Laboratories AB CHIX:RAYBS
95 GF Score
Price kr215.50
GF Value kr180.42
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is RaySearch Laboratories AB Other Financing?

RaySearch Laboratories AB CHIX:RAYBS 95 Other Financing is kr-0 Mil as of Mar. 2026. GuruFocus rates CHIX:RAYBS with a GF Score™ of 95/100 and a GF Value™ of kr180.42 (Modestly Overvalued). The stock has 2 warning signs investors should review.

RaySearch Laboratories AB's Other Financing for the three months ended in Mar. 2026 was kr0 Mil.

RaySearch Laboratories AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0 Mil.

RaySearch Laboratories AB Other Financing Historical Data

* Premium members only.

The historical data trend for RaySearch Laboratories AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RaySearch Laboratories AB Other Financing Chart

RaySearch Laboratories AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.10

RaySearch Laboratories AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.05 0.00 0.00
CHIX:RAYBS
95GF Score
RaySearch Laboratories AB CHIX:RAYBS
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RaySearch Laboratories AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-0 Mil mean?
RaySearch Laboratories AB (CHIX:RAYBS) has a Other Financing of kr-0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's Other Financing too high?
RaySearch Laboratories AB's current Other Financing is kr-0 Mil. Overall, RaySearch Laboratories AB has a GF Score™ of 95/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Other Financing compare to VEEV and BTSG?
RaySearch Laboratories AB's Other Financing of kr-0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Other Financing is kr-0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (CHIX:RAYBS) is currently considered Modestly Overvalued. The stock's GF Value™ is kr180.42, compared to a current price of kr215.50 — trading 19.4% above its estimated fair value. The current Other Financing is kr-0 Mil. RaySearch Laboratories AB's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For RaySearch Laboratories AB (CHIX:RAYBS), the current Other Financing is kr-0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RaySearch Laboratories AB (CHIX:RAYBS) Overvalued in 2026?

Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued. The current stock price of kr215.50 is trading 19.4% above its estimated GF Value™ of kr180.42. GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.

Key valuation signals for CHIX:RAYBS:

  • Other Financing: kr-0 Mil
  • GF Value™: kr180.42 vs. price of kr215.50 (19.4% above fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the CHIX:RAYBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RaySearch Laboratories AB Business Description

Address Eugeniavagen 18C, Stockholm, SWE, 113 68
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
95GF Score

Get the complete analysis for CHIX:RAYBS

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr215.50
Price
kr180.42
GF Value